Vergoeding 2019-2023 voor ATC-subgroep L04A : Immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L04AA Selectieve immunosuppressiva | 21.204.800 | 19.628.700 | 16.101.700 | 20.825.100 | 26.347.900 |
| L04AD Calcineurineremmers | 39.447.600 | 38.533.200 | 32.928.400 | 34.321.800 | 35.576.400 |
| L04AE Sfingosine-1-fosfaat (s1p) receptormodulatoren | 23.131.200 | 21.649.200 | 26.729.600 | 31.966.200 | 31.342.500 |
| L04AG Monoklonale antilichamen | . | . | . | 1.525.100 | 5.724.200 |
| L04AH Mtor-kinaseremmers | 6.468.900 | 6.240.200 | 6.228.800 | 7.228.800 | 7.419.100 |
| L04AK Dhodh-remmers | 16.205.600 | 16.140.200 | 16.989.300 | 17.424.600 | 17.284.600 |
| L04AX Overige immunosuppressiva | 82.917.200 | 85.781.800 | 83.535.400 | 86.617.400 | 83.247.900 |
| Totaal | 189.375.300 | 187.973.300 | 182.513.200 | 199.909.000 | 206.942.600 |